ArticleThe Lancet. Oncology2021
Should stereotactic ablative body radiotherapy be the standard of care in oligometastatic cancer?
Rohann J M Correa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it